Important: No clinical trials exist for the CJC-1295/Ipamorelin blend formulation. CJC-1295 has limited human pharmacokinetic data only; ipamorelin evidence is preclinical. Blend synergy claims are theoretical. This combination is not FDA-approved for any indication.
Overview
Testagen (KEDG) is a synthetic tetrapeptide bioregulator developed within the framework of Professor Vladimir Khavinson's peptide bioregulator research program at the St. Petersburg Institute of Bioregulation and Gerontology. The compound consists of four amino acids — Lysine, Glutamic acid, Aspartic acid, and Glycine — arranged in a sequence that mirrors naturally occurring regulatory peptides originally isolated from testicular and anterior pituitary tissue. Unlike most peptide therapeutics that bind to cell surface receptors to trigger downstream signaling cascades, Testagen belongs to a class of short regulatory peptides hypothesized to operate at the epigenetic level. Research suggests these tetrapeptides can penetrate cellular and nuclear membranes, interacting directly with histone proteins and chromatin to influence gene expression patterns. This mechanism positions Testagen as
Mechanism of Action
CJC-1295 activates GHRH receptors on somatotroph cells in the anterior pituitary, stimulating GH synthesis and release. Ipamorelin simultaneously activates GHSR-1a (ghrelin receptor) on the same cells, providing a complementary and synergistic signal. The combination produces GH release significantly greater than either peptide alone, while preserving the natural pulsatile pattern.
Research Evidence
- Synergistic dual-receptor GH stimulation (GHRH + GHSR-1a pathways)
- CJC-1295 produces sustained GH elevation for up to 6 days after a single injection (JCEM, 2006)
- Ipamorelin is selective for GH release — does not stimulate cortisol or prolactin
- Preserves natural pulsatile GH secretion pattern, maintaining receptor sensitivity
- Most studied GH secretagogue combination protocol in research literature
Bottom line: The CJC-1295/Ipamorelin blend is the gold standard GH secretagogue combination — synergistic dual-receptor activation, pulsatile GH release, and selective action without cortisol or prolactin elevation.
Research Protocols & Dosage
Evidence-based research protocols, administration routes, and dosage considerations for CJC/Ipamorelin Blend are detailed in the full compound profile. See also: Dosage guide for CJC/Ipamorelin Blend.
Sourcing & Quality
CJC/Ipamorelin Blend is available from Purgo Labs with third-party COA verification and research-grade purity standards. View CJC/Ipamorelin Blend at Purgo Labs.